Eeyarestatin 21799938 ? I-treatment
1 ? ? I-treatment
interferes ? ? O
with ? ? O
both ? ? O
retrograde ? ? O
and ? ? O
anterograde ? ? O
intracellular ? ? O
trafficking ? ? O
pathways ? ? O
. ? ? O

BACKGROUND 21799938 ? O
: ? ? O
The ? ? O
small ? ? O
molecule ? ? O
Eeyarestatin ? ? I-treatment
I ? ? I-treatment
( ? ? O
ESI ? ? I-treatment
) ? ? O
inhibits ? ? O
the ? ? O
endoplasmic ? ? O
reticulum ? ? O
( ? ? O
ER ? ? O
) ? ? O
-cytosol ? ? O
dislocation ? ? O
and ? ? O
subsequent ? ? O
degradation ? ? I-disease
of ? ? I-disease
ERAD ? ? I-disease
( ? ? O
ER ? ? I-disease
associated ? ? I-disease
protein ? ? I-disease
degradation ? ? I-disease
) ? ? O
substrates ? ? O
. ? ? O

Toxins 21799938 ? I-treatment
such ? ? O
as ? ? O
ricin ? ? O
and ? ? O
Shiga ? ? O
/ ? ? O
Shiga-like ? ? O
toxins ? ? O
( ? ? O
SLTx ? ? O
) ? ? O
are ? ? O
endocytosed ? ? O
and ? ? O
trafficked ? ? O
to ? ? O
the ? ? O
ER ? ? O
. ? ? O

Their 21799938 ? O
catalytic ? ? O
subunits ? ? O
are ? ? O
thought ? ? O
to ? ? O
utilise ? ? O
ERAD-like ? ? O
mechanisms ? ? O
to ? ? O
dislocate ? ? O
from ? ? O
the ? ? O
ER ? ? O
into ? ? O
the ? ? O
cytosol ? ? O
, ? ? O
where ? ? O
a ? ? O
proportion ? ? O
uncouples ? ? O
from ? ? O
the ? ? O
ERAD ? ? O
process ? ? O
, ? ? O
recovers ? ? O
a ? ? O
catalytic ? ? O
conformation ? ? O
and ? ? O
destroys ? ? O
their ? ? O
cellular ? ? O
targets ? ? O
. ? ? O

We 21799938 ? O
therefore ? ? O
investigated ? ? O
ESI ? ? O
as ? ? O
a ? ? O
potential ? ? O
inhibitor ? ? O
of ? ? O
toxin ? ? O
dislocation ? ? O
. ? ? O

METHODOLOGY 21799938 ? O
AND ? ? O
PRINCIPAL ? ? O
FINDINGS ? ? O
: ? ? O
Using ? ? O
cytotoxicity ? ? O
measurements ? ? O
, ? ? O
we ? ? O
found ? ? O
no ? ? O
role ? ? O
for ? ? O
ES ? ? I-treatment
( ? ? O
I ? ? O
) ? ? O
as ? ? O
an ? ? O
inhibitor ? ? O
of ? ? O
toxin ? ? I-disease
dislocation ? ? I-disease
from ? ? I-disease
the ? ? I-disease
ER ? ? I-disease
, ? ? O
but ? ? O
instead ? ? O
found ? ? O
that ? ? O
for ? ? O
SLTx ? ? O
, ? ? O
ESI ? ? I-treatment
treatment ? ? O
of ? ? O
cells ? ? O
was ? ? O
protective ? ? O
by ? ? O
reducing ? ? O
the ? ? O
rate ? ? O
of ? ? O
toxin ? ? O
delivery ? ? O
to ? ? O
the ? ? O
ER ? ? O
. ? ? O

Microscopy 21799938 ? O
of ? ? O
the ? ? O
trafficking ? ? O
of ? ? O
labelled ? ? O
SLTx ? ? O
and ? ? O
its ? ? O
B ? ? O
chain ? ? O
( ? ? O
lacking ? ? O
the ? ? O
toxic ? ? O
A ? ? O
chain ? ? O
) ? ? O
showed ? ? O
a ? ? O
delay ? ? O
in ? ? O
its ? ? O
accumulation ? ? O
at ? ? O
a ? ? O
peri-nuclear ? ? O
location ? ? O
, ? ? O
confirmed ? ? O
to ? ? O
be ? ? O
the ? ? O
Golgi ? ? O
by ? ? O
examination ? ? O
of ? ? O
SLTx ? ? O
B ? ? O
chain ? ? O
metabolically ? ? O
labelled ? ? O
in ? ? O
the ? ? O
trans-Golgi ? ? O
cisternae ? ? O
. ? ? O

The 21799938 ? O
drug ? ? O
also ? ? O
reduced ? ? O
the ? ? O
rate ? ? O
of ? ? O
endosomal ? ? O
trafficking ? ? O
of ? ? O
diphtheria ? ? O
toxin ? ? O
, ? ? O
which ? ? O
enters ? ? O
the ? ? O
cytosol ? ? O
from ? ? O
acidified ? ? O
endosomes ? ? O
, ? ? O
and ? ? O
delayed ? ? O
the ? ? O
Golgi-specific ? ? O
glycan ? ? O
modifications ? ? O
and ? ? O
eventual ? ? O
plasma ? ? O
membrane ? ? O
appearance ? ? O
of ? ? O
tsO45 ? ? O
VSV-G ? ? O
protein ? ? O
, ? ? O
a ? ? O
classical ? ? O
marker ? ? O
for ? ? O
anterograde ? ? O
trafficking ? ? O
. ? ? O

CONCLUSIONS 21799938 ? O
AND ? ? O
SIGNIFICANCE ? ? O
: ? ? O
ESI ? ? I-treatment
acts ? ? O
on ? ? O
one ? ? O
or ? ? O
more ? ? O
components ? ? O
that ? ? O
function ? ? O
during ? ? O
vesicular ? ? O
transport ? ? O
, ? ? O
whilst ? ? O
at ? ? O
least ? ? O
one ? ? O
retrograde ? ? O
trafficking ? ? O
pathway ? ? O
, ? ? O
that ? ? O
of ? ? O
ricin ? ? O
, ? ? O
remains ? ? O
unperturbed ? ? O
. ? ? O

Inhibition 22006919 ? I-treatment
of ? ? I-treatment
endoplasmic ? ? I-treatment
reticulum-associated ? ? I-treatment
degradation ? ? I-treatment
rescues ? ? O
native ? ? O
folding ? ? O
in ? ? O
loss ? ? O
of ? ? O
function ? ? I-disease
protein ? ? I-disease
misfolding ? ? I-disease
diseases ? ? I-disease
. ? ? O

Lysosomal 22006919 ? I-disease
storage ? ? I-disease
disorders ? ? I-disease
are ? ? O
often ? ? O
caused ? ? O
by ? ? O
mutations ? ? O
that ? ? O
destabilize ? ? I-disease
native ? ? I-disease
folding ? ? I-disease
and ? ? I-disease
impair ? ? I-disease
trafficking ? ? I-disease
of ? ? I-disease
secretory ? ? I-disease
proteins ? ? I-disease
. ? ? O

We 22006919 ? O
demonstrate ? ? O
that ? ? O
endoplasmic ? ? I-disease
reticulum ? ? I-disease
( ? ? I-disease
ER ? ? I-disease
) ? ? I-disease
-associated ? ? I-disease
degradation ? ? I-disease
( ? ? O
ERAD ? ? I-disease
) ? ? O
prevents ? ? O
native ? ? O
folding ? ? O
of ? ? O
mutated ? ? I-treatment
lysosomal ? ? I-treatment
enzymes ? ? I-treatment
in ? ? O
patient-derived ? ? O
fibroblasts ? ? O
from ? ? O
two ? ? O
clinically ? ? O
distinct ? ? O
lysosomal ? ? I-disease
storage ? ? I-disease
disorders ? ? I-disease
, ? ? O
namely ? ? O
Gaucher ? ? I-disease
and ? ? O
Tay-Sachs ? ? I-disease
disease ? ? I-disease
. ? ? O

Prolonging 22006919 ? O
ER ? ? O
retention ? ? O
via ? ? O
ERAD ? ? I-treatment
inhibition ? ? I-treatment
enhanced ? ? O
folding ? ? O
, ? ? O
trafficking ? ? O
, ? ? O
and ? ? O
activity ? ? O
of ? ? O
these ? ? O
unstable ? ? O
enzyme ? ? O
variants ? ? O
. ? ? O

Furthermore 22006919 ? O
, ? ? O
combining ? ? O
ERAD ? ? I-treatment
inhibition ? ? I-treatment
with ? ? O
enhancement ? ? O
of ? ? O
the ? ? O
cellular ? ? O
folding ? ? O
capacity ? ? O
via ? ? O
proteostasis ? ? I-treatment
modulation ? ? I-treatment
resulted ? ? O
in ? ? O
synergistic ? ? O
rescue ? ? O
of ? ? O
mutated ? ? O
enzymes ? ? O
. ? ? O

ERAD 22006919 ? I-treatment
inhibition ? ? I-treatment
was ? ? O
achieved ? ? O
by ? ? O
cell ? ? O
treatment ? ? O
with ? ? O
small ? ? O
molecules ? ? O
that ? ? O
interfere ? ? O
with ? ? O
recognition ? ? O
( ? ? O
kifunensine ? ? I-treatment
) ? ? O
or ? ? O
retrotranslocation ? ? O
( ? ? O
eeyarestatin ? ? I-treatment
I ? ? I-treatment
) ? ? O
of ? ? O
misfolded ? ? O
substrates ? ? O
. ? ? O

These 22006919 ? O
different ? ? O
mechanisms ? ? O
of ? ? O
ERAD ? ? I-treatment
inhibition ? ? I-treatment
were ? ? O
shown ? ? O
to ? ? O
enhance ? ? O
ER ? ? O
retention ? ? O
of ? ? O
mutated ? ? O
proteins ? ? O
but ? ? O
were ? ? O
associated ? ? O
with ? ? O
dramatically ? ? O
different ? ? O
levels ? ? O
of ? ? O
ER ? ? I-disease
stress ? ? I-disease
, ? ? I-disease
unfolded ? ? I-disease
protein ? ? I-disease
response ? ? I-disease
activation ? ? I-disease
, ? ? I-disease
and ? ? I-disease
unfolded ? ? I-disease
protein ? ? I-disease
response-induced ? ? I-disease
apoptosis ? ? I-disease
. ? ? O

A 23720739 ? O
connexin50 ? ? I-gene
mutant ? ? I-gene
, ? ? O
CX50fs ? ? I-gene
, ? ? O
that ? ? O
causes ? ? O
cataracts ? ? O
is ? ? O
unstable ? ? O
, ? ? O
but ? ? O
is ? ? O
rescued ? ? O
by ? ? O
a ? ? O
proteasomal ? ? I-treatment
inhibitor ? ? I-treatment
. ? ? O

The 23720739 ? O
mechanisms ? ? O
by ? ? O
which ? ? O
mutant ? ? O
connexins ? ? O
lead ? ? O
to ? ? O
disease ? ? O
are ? ? O
diverse ? ? O
, ? ? O
including ? ? O
those ? ? O
of ? ? O
connexin50 ? ? I-gene
( ? ? O
CX50 ? ? I-gene
) ? ? O
encoded ? ? O
by ? ? O
the ? ? O
GJA8 ? ? I-gene
gene ? ? O
. ? ? O

We 23720739 ? O
investigated ? ? O
the ? ? O
cellular ? ? O
and ? ? O
functional ? ? O
behavior ? ? O
of ? ? O
CX50fs ? ? I-gene
, ? ? O
a ? ? O
mutant ? ? O
CX50 ? ? I-gene
that ? ? O
has ? ? O
a ? ? O
frameshift ? ? O
after ? ? O
amino ? ? I-gene
acid ? ? I-gene
255 ? ? I-gene
and ? ? O
causes ? ? O
recessive ? ? I-disease
congenital ? ? I-disease
cataracts ? ? I-disease
. ? ? O

Cellular 23720739 ? O
levels ? ? O
of ? ? O
CX50fs ? ? I-gene
were ? ? O
much ? ? O
lower ? ? O
than ? ? O
those ? ? O
of ? ? O
wild ? ? O
type ? ? O
CX50 ? ? I-gene
in ? ? O
stably ? ? O
transfected ? ? O
HeLa ? ? O
cells ? ? O
. ? ? O

Whereas 23720739 ? O
CX50 ? ? I-gene
localized ? ? O
at ? ? O
distinct ? ? O
gap ? ? O
junction ? ? O
plaques ? ? O
and ? ? O
supported ? ? O
extensive ? ? O
intercellular ? ? O
transfer ? ? O
of ? ? O
Neurobiotin ? ? O
, ? ? O
CX50fs ? ? I-gene
gap ? ? O
junctions ? ? O
were ? ? O
rare ? ? O
, ? ? O
and ? ? O
their ? ? O
support ? ? O
of ? ? O
Neurobiotin ? ? I-gene
transfer ? ? O
was ? ? O
reduced ? ? O
by ? ? O
> ? ? O
90 ? ? O
% ? ? O
. ? ? O

After 23720739 ? O
inhibition ? ? O
of ? ? O
new ? ? O
protein ? ? O
synthesis ? ? O
with ? ? O
cycloheximide ? ? I-treatment
, ? ? O
CX50fs ? ? I-gene
disappeared ? ? O
much ? ? O
more ? ? O
rapidly ? ? O
than ? ? O
CX50 ? ? I-gene
, ? ? O
suggesting ? ? O
increased ? ? O
degradation ? ? O
of ? ? O
the ? ? O
mutant ? ? O
. ? ? O

Treatment 23720739 ? O
of ? ? O
cells ? ? O
with ? ? O
epoxomicin ? ? I-treatment
( ? ? O
a ? ? O
proteasomal ? ? I-treatment
inhibitor ? ? I-treatment
) ? ? O
led ? ? O
to ? ? O
a ? ? O
dramatic ? ? O
increase ? ? O
in ? ? O
CX50fs ? ? I-gene
levels ? ? O
and ? ? O
in ? ? O
the ? ? O
abundance ? ? O
of ? ? O
gap ? ? O
junctions ? ? O
. ? ? O

Epoxomicin 23720739 ? I-treatment
treatment ? ? O
also ? ? O
rescued ? ? O
intercellular ? ? O
transfer ? ? O
of ? ? O
Neurobiotin ? ? I-gene
to ? ? O
levels ? ? O
similar ? ? O
to ? ? O
those ? ? O
in ? ? O
cells ? ? O
expressing ? ? O
the ? ? O
wild ? ? O
type ? ? O
protein ? ? O
. ? ? O

Treatment 23720739 ? O
with ? ? O
eeyarestatin ? ? O
I ? ? O
( ? ? O
an ? ? O
inhibitor ? ? O
of ? ? O
p97-dependent ? ? O
protein ? ? O
degradation ? ? O
) ? ? O
resulted ? ? O
in ? ? O
many ? ? O
abundant ? ? O
slowly ? ? O
migrating ? ? O
CX50 ? ? I-gene
and ? ? O
CX50fs ? ? I-gene
bands ? ? O
consistent ? ? O
with ? ? O
polyubiquitination ? ? O
of ? ? O
the ? ? O
proteins ? ? O
. ? ? O

These 23720739 ? O
results ? ? O
demonstrate ? ? O
that ? ? O
the ? ? O
CX50fs ? ? I-gene
mutant ? ? O
is ? ? O
rapidly ? ? O
degraded ? ? O
by ? ? O
endoplasmic ? ? O
reticulum-associated ? ? O
degradation ? ? O
in ? ? O
mammalian ? ? O
cells ? ? O
. ? ? O

This 23720739 ? O
accelerated ? ? O
degradation ? ? O
reduces ? ? O
the ? ? O
abundance ? ? O
of ? ? O
gap ? ? O
junctions ? ? O
and ? ? O
the ? ? O
extent ? ? O
of ? ? O
intercellular ? ? O
communication ? ? O
, ? ? O
potentially ? ? O
explaining ? ? O
the ? ? O
pathogenesis ? ? O
of ? ? O
cataracts ? ? O
linked ? ? O
to ? ? O
this ? ? O
mutant ? ? O
. ? ? O

The 23720739 ? O
efficacy ? ? O
of ? ? O
epoxomicin ? ? I-treatment
in ? ? O
restoring ? ? O
function ? ? O
suggests ? ? O
that ? ? O
protease ? ? I-treatment
inhibition ? ? I-treatment
might ? ? O
have ? ? O
therapeutic ? ? O
value ? ? O
for ? ? O
this ? ? O
and ? ? O
other ? ? O
diseases ? ? O
caused ? ? O
by ? ? O
mutants ? ? O
with ? ? O
similar ? ? O
defects ? ? O
. ? ? O

The 24196352 ? O
type ? ? I-gene
II ? ? I-gene
deiodinase ? ? I-gene
is ? ? O
retrotranslocated ? ? O
to ? ? O
the ? ? O
cytoplasm ? ? O
and ? ? O
proteasomes ? ? O
via ? ? O
p97 ? ? I-gene
/ ? ? O
Atx3 ? ? I-gene
complex ? ? I-gene
. ? ? O

The 24196352 ? O
type ? ? I-gene
II ? ? I-gene
iodothyronine ? ? I-gene
deiodinase ? ? I-gene
( ? ? O
D2 ? ? I-gene
) ? ? O
is ? ? O
a ? ? O
type ? ? O
I ? ? O
endoplasmic ? ? O
reticulum ? ? O
( ? ? O
ER ? ? O
) ? ? O
-resident ? ? O
thioredoxin ? ? O
fold-containing ? ? O
selenoprotein ? ? O
that ? ? O
activates ? ? O
thyroid ? ? I-gene
hormone ? ? I-gene
. ? ? O

D2 24196352 ? I-gene
is ? ? O
inactivated ? ? O
by ? ? O
ER-associated ? ? I-treatment
ubiquitination ? ? I-treatment
and ? ? O
can ? ? O
be ? ? O
reactivated ? ? O
by ? ? O
two ? ? O
ubiquitin-specific ? ? O
peptidase-class ? ? I-gene
D2-interacting ? ? I-gene
deubiquitinases ? ? I-gene
( ? ? O
DUBs ? ? I-gene
) ? ? O
. ? ? O

Here 24196352 ? O
, ? ? O
we ? ? O
used ? ? O
D2-expressing ? ? O
cell ? ? O
models ? ? O
to ? ? O
define ? ? O
that ? ? O
D2 ? ? I-gene
ubiquitination ? ? I-gene
( ? ? O
UbD2 ? ? I-gene
) ? ? O
occurs ? ? O
via ? ? O
K48-linked ? ? O
ubiquitin ? ? O
chains ? ? O
and ? ? O
that ? ? O
exposure ? ? O
to ? ? O
its ? ? O
natural ? ? O
substrate ? ? O
, ? ? O
T4 ? ? I-gene
, ? ? O
accelerates ? ? O
UbD2 ? ? I-gene
formation ? ? O
and ? ? O
retrotranslocation ? ? O
to ? ? O
the ? ? O
cytoplasm ? ? O
via ? ? O
interaction ? ? O
with ? ? O
the ? ? O
p97-ATPase ? ? I-gene
complex ? ? I-gene
. ? ? O

D2 24196352 ? O
retrotranslocation ? ? O
also ? ? O
includes ? ? O
deubiquitination ? ? O
by ? ? O
the ? ? O
p97-associated ? ? I-gene
DUB ? ? I-gene
Ataxin-3 ? ? I-gene
( ? ? O
Atx3 ? ? I-gene
) ? ? O
. ? ? O

Inhibiting 24196352 ? O
Atx3 ? ? I-gene
with ? ? O
eeyarestatin-I ? ? I-treatment
did ? ? O
not ? ? O
affect ? ? O
D2 ? ? I-gene
: ? ? O
p97 ? ? I-gene
binding ? ? O
but ? ? O
decreased ? ? O
UbD2 ? ? I-gene
retrotranslocation ? ? O
and ? ? O
caused ? ? O
ER ? ? O
accumulation ? ? O
of ? ? O
high-molecular ? ? O
weight ? ? O
UbD2 ? ? I-gene
bands ? ? O
possibly ? ? O
by ? ? O
interfering ? ? O
with ? ? O
the ? ? O
D2-ubiquitin-specific ? ? I-gene
peptidases ? ? I-gene
binding ? ? O
. ? ? O

Once 24196352 ? O
in ? ? O
the ? ? O
cytosol ? ? O
, ? ? O
D2 ? ? I-gene
is ? ? O
delivered ? ? O
to ? ? O
the ? ? O
proteasomes ? ? O
as ? ? O
evidenced ? ? O
by ? ? O
coprecipitation ? ? O
with ? ? O
19S ? ? I-gene
proteasome ? ? I-gene
subunit ? ? I-gene
S5a ? ? I-gene
and ? ? O
increased ? ? O
colocalization ? ? O
with ? ? O
the ? ? O
20S ? ? I-gene
proteasome ? ? I-gene
. ? ? O

We 24196352 ? O
conclude ? ? O
that ? ? O
interaction ? ? O
between ? ? O
UbD2 ? ? I-gene
and ? ? O
p97 ? ? I-gene
/ ? ? O
Atx3 ? ? I-gene
mediates ? ? O
retranslocation ? ? O
of ? ? O
UbD2 ? ? I-gene
to ? ? O
the ? ? O
cytoplasm ? ? O
for ? ? O
terminal ? ? O
degradation ? ? O
in ? ? O
the ? ? O
proteasomes ? ? O
, ? ? O
a ? ? O
pathway ? ? O
that ? ? O
is ? ? O
accelerated ? ? O
by ? ? O
exposure ? ? O
to ? ? O
T4 ? ? I-gene
. ? ? O

Alteration 24713615 ? O
of ? ? O
the ? ? O
proteostasis ? ? O
network ? ? O
of ? ? O
plant ? ? O
cells ? ? O
promotes ? ? O
the ? ? O
post-endoplasmic ? ? O
reticulum ? ? O
trafficking ? ? O
of ? ? O
recombinant ? ? O
mutant ? ? O
( ? ? O
L444P ? ? I-gene
) ? ? O
human ? ? I-gene
beta-glucocerebrosidase ? ? I-gene
. ? ? O

Gaucher 24713615 ? I-disease
disease ? ? I-disease
is ? ? O
a ? ? O
prevalent ? ? O
lysosomal ? ? I-disease
storage ? ? I-disease
disease ? ? I-disease
characterized ? ? O
by ? ? O
a ? ? O
deficiency ? ? O
in ? ? O
the ? ? O
activity ? ? O
of ? ? O
lysosomal ? ? I-gene
acid ? ? I-gene
beta-glucosidase ? ? I-gene
( ? ? O
glucocerebrosidase ? ? I-gene
, ? ? O
GCase ? ? I-gene
, ? ? O
EC ? ? I-gene
3.2.1.45 ? ? I-gene
) ? ? O
. ? ? O

One 24713615 ? O
of ? ? O
the ? ? O
most ? ? O
prevalent ? ? O
disease-causing ? ? O
mutations ? ? O
in ? ? O
humans ? ? O
is ? ? O
a ? ? O
L444P ? ? I-gene
missense ? ? O
mutation ? ? O
in ? ? O
the ? ? O
GCase ? ? I-gene
protein ? ? O
, ? ? O
which ? ? O
results ? ? O
in ? ? O
its ? ? O
disrupted ? ? O
folding ? ? O
in ? ? O
the ? ? O
endoplasmic ? ? O
reticulum ? ? O
( ? ? O
ER ? ? O
) ? ? O
and ? ? O
impaired ? ? O
post-ER ? ? O
trafficking ? ? O
. ? ? O

To 24713615 ? O
determine ? ? O
whether ? ? O
the ? ? O
post-ER ? ? O
trafficking ? ? O
of ? ? O
this ? ? O
severely ? ? O
malfolded ? ? O
protein ? ? O
can ? ? O
be ? ? O
restored ? ? O
, ? ? O
we ? ? O
expressed ? ? O
the ? ? O
mutant ? ? O
L444P ? ? I-gene
GCase ? ? I-gene
as ? ? O
a ? ? O
recombinant ? ? O
protein ? ? O
in ? ? O
transgenic ? ? O
tobacco ? ? O
( ? ? O
Nicotiana ? ? O
tabacum ? ? O
L. ? ? O
cv ? ? O
Bright ? ? O
Yellow ? ? O
2 ? ? O
[ ? ? O
BY2 ? ? O
] ? ? O
) ? ? O
cells ? ? O
, ? ? O
in ? ? O
which ? ? O
the ? ? O
GCase ? ? I-gene
variant ? ? O
was ? ? O
equipped ? ? O
with ? ? O
a ? ? O
plant ? ? I-gene
signal ? ? I-gene
peptide ? ? I-gene
to ? ? O
allow ? ? O
for ? ? O
secretion ? ? O
upon ? ? O
rescued ? ? O
trafficking ? ? O
out ? ? I-disease
of ? ? O
the ? ? O
ER ? ? O
. ? ? O

The 24713615 ? O
recombinant ? ? O
L444P ? ? I-gene
mutant ? ? I-gene
GCase ? ? I-gene
was ? ? O
retained ? ? O
in ? ? O
the ? ? O
plant ? ? O
endoplasmic ? ? O
reticulum ? ? O
( ? ? O
ER ? ? O
) ? ? O
. ? ? O

Kifunensine 24713615 ? I-treatment
and ? ? O
Eeyarestatin ? ? I-treatment
I ? ? I-treatment
, ? ? O
both ? ? O
inhibitors ? ? O
of ? ? O
ER-associated ? ? O
degradation ? ? O
( ? ? O
ERAD ? ? O
) ? ? O
, ? ? O
and ? ? O
the ? ? O
proteostasis ? ? I-treatment
regulators ? ? I-treatment
, ? ? O
celastrol ? ? I-treatment
and ? ? O
MG-132 ? ? I-treatment
, ? ? O
increased ? ? O
the ? ? O
steady-state ? ? O
levels ? ? O
of ? ? O
the ? ? O
mutant ? ? O
protein ? ? O
inside ? ? O
the ? ? O
plant ? ? O
cells ? ? O
and ? ? O
further ? ? O
promoted ? ? O
the ? ? O
post-ER ? ? O
trafficking ? ? O
of ? ? O
L444P ? ? I-gene
GCase ? ? I-gene
, ? ? O
as ? ? O
indicated ? ? O
by ? ? O
endoglycosidase-H ? ? O
sensitivity- ? ? O
and ? ? O
secretion- ? ? O
analyses ? ? O
. ? ? O

Transcript 24713615 ? O
profiling ? ? O
of ? ? O
genes ? ? O
encoding ? ? O
ER-molecular ? ? O
chaperones ? ? O
, ? ? O
ER ? ? O
stress ? ? O
responsive ? ? O
proteins ? ? O
, ? ? O
and ? ? O
cytoplasmic ? ? O
heat ? ? O
shock ? ? O
response ? ? O
proteins ? ? O
, ? ? O
revealed ? ? O
insignificant ? ? O
or ? ? O
only ? ? O
very ? ? O
modest ? ? O
changes ? ? O
in ? ? O
response ? ? O
to ? ? O
the ? ? O
ERAD ? ? I-treatment
inhibitors ? ? I-treatment
and ? ? O
proteostasis ? ? I-treatment
regulators ? ? I-treatment
. ? ? O

An 24713615 ? O
exception ? ? O
was ? ? O
the ? ? O
marked ? ? O
response ? ? O
to ? ? I-disease
celastrol ? ? I-treatment
which ? ? O
reduced ? ? O
the ? ? O
steady-state ? ? O
levels ? ? O
of ? ? O
cytoplasmic ? ? I-gene
HSP90 ? ? I-gene
transcripts ? ? O
and ? ? O
protein ? ? O
. ? ? O

As 24713615 ? O
Hsp90 ? ? I-gene
participates ? ? O
in ? ? O
the ? ? O
targeting ? ? O
of ? ? O
misfolded ? ? O
proteins ? ? O
to ? ? O
the ? ? O
proteasome ? ? O
pathway ? ? O
, ? ? O
its ? ? O
down-modulation ? ? O
in ? ? O
response ? ? O
to ? ? O
celastrol ? ? I-treatment
may ? ? O
partly ? ? O
account ? ? O
for ? ? O
the ? ? O
mechanism ? ? O
of ? ? O
improved ? ? O
homeostasis ? ? O
of ? ? O
L444P ? ? I-gene
GCase ? ? I-gene
mediated ? ? O
by ? ? O
this ? ? O
triterpene ? ? O
. ? ? O

